All Pathways
AnesthesiologyEmergency

Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020)

Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020): Suspect LAST → LAST Signs Present? → Call for Help & Get Lipid Emulsion → Airway Manag...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspect LAST

    Signs/symptoms during or after local anesthetic administration

    1. Decision

      LAST Signs Present?

      CNS and/or cardiovascular toxicity

      • CNS EXCITATION: agitation, confusion, metallic taste, tinnitus, perioral numbness, seizures
      • CNS DEPRESSION: drowsiness, obtundation, coma, respiratory arrest
      • CV SIGNS: hypotension, bradycardia, arrhythmias, asystole
      • Atypical presentations common - maintain high index of suspicion
      1. Action

        Call for Help & Get Lipid Emulsion

        Immediate actions

        • Stop injection of local anesthetic immediately
        • Call for help
        • Get LAST rescue kit (lipid emulsion 20%)
        • Consider calling ACLS team
        • Designate team leader
        1. Action

          Airway Management

          Prevent hypoxia and acidosis which worsen toxicity

          • 100% oxygen via mask or secure airway
          • Ventilate if apneic
          • Prevent aspiration
          • Avoid hyperventilation (may worsen CNS toxicity)
          1. Decision

            Seizure Activity?

            Treat seizures promptly to prevent acidosis

            1. Action

              Treat Seizures

              Benzodiazepines preferred

              • Midazolam 2-4 mg IV or
              • Diazepam 5-10 mg IV or
              • Lorazepam 2-4 mg IV
              • Avoid large propofol doses (cardiac depression)
              • If refractory: consider small propofol doses
              • Succinylcholine stops motor activity but not CNS seizure
              1. Decision

                Cardiac Instability or Arrest?

                Hypotension, arrhythmia, or cardiac arrest

                1. Action

                  Lipid Emulsion 20% Therapy

                  CRITICAL: Start lipid even if stable but symptomatic

                  • BOLUS: 1.5 mL/kg over 1 minute (~100 mL for 70 kg)
                  • INFUSION: 0.25 mL/kg/min
                  • If unstable: repeat bolus 1-2 times at 3-5 min intervals
                  • Double infusion to 0.5 mL/kg/min if unstable
                  • Continue infusion ≥15 min after hemodynamic stability
                  • Maximum ~10-12 mL/kg in first 30 minutes
                  1. Warning

                    ⚠️ AVOID These Drugs

                    Contraindicated in LAST:

                    • Vasopressin
                    • Calcium channel blockers
                    • Beta-blockers
                    • Additional local anesthetics (e.g., lidocaine for arrhythmia)
                    • Large doses of propofol
                  2. Action

                    Monitoring & Post-Event

                    Observe for recurrence

                    • Monitor ≥4-6 hours after treatment
                    • Watch for recurrence (may occur for up to 2 hours)
                    • Report event to www.lipidrescue.org
                    • Obtain serum LA levels if available
                    • Document carefully for future care
                    1. Outcome

                      Patient Stabilized

                      Continue monitoring, document event

                2. Warning

                  ⚠️ CARDIAC ARREST

                  Modified CPR + Lipid therapy

                  • Start CPR immediately
                  • Give lipid bolus AND infusion as above
                  • REDUCE epinephrine dose to <1 mcg/kg
                  • AVOID: vasopressin, calcium channel blockers, beta-blockers, lidocaine
                  • Consider prolonged resuscitation (>60 min) - lipid may delay recovery
                  • Consider ECMO/CPB if available

Guideline Source

American Society of Regional Anesthesia and Pain Medicine Local Anesthetic Systemic Toxicity Checklist: 2020 Version

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Lipid emulsion must be immediately available
  • Does not cover delayed presentations
  • Pediatric dosing may require adjustment
  • May mask bupivacaine cardiotoxicity recovery

Applicable Regions

USEUglobal

EU: Compatible with ESRA recommendations

US: Based on ASRA 2020 guidelines

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020)?

The Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020) is a emergency clinical algorithm for Anesthesiology. It provides a structured decision tree to guide clinical decision-making, based on American Society of Regional Anesthesia and Pain Medicine Local Anesthetic Systemic Toxicity Checklist: 2020 Version.

What guideline is the Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020) based on?

This algorithm is based on American Society of Regional Anesthesia and Pain Medicine Local Anesthetic Systemic Toxicity Checklist: 2020 Version (DOI: 10.1136/rapm-2020-101986).

What are the limitations of the Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020)?

Known limitations include: Lipid emulsion must be immediately available; Does not cover delayed presentations; Pediatric dosing may require adjustment; May mask bupivacaine cardiotoxicity recovery. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Local Anesthetic Systemic Toxicity (LAST) Management (ASRA 2020) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free